Clinical Trial Update: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating how much CagriSema lowers blood sugar and body weight compared with placebo in children and adolescents with Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: NOT_YET_RECRUITING